Home › Asset managers › Capital Group › 2025-2026 › Against the board
835 proposals in the 2025-2026 proxy season: Capital Group voted against, or withheld its votes from, 829 proposals put forward by company boards, and voted for 6 shareholder proposals, by its own Form N-PX filings.
Two kinds of vote are listed: a board-sponsored proposal Capital Group voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
The list includes the pay votes in Capital Group’s institutional-manager report, which by rule covers only executive pay.
Everything Only shareholder proposals it backed
835 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | Capital Group voted | Funds |
|---|---|---|---|---|---|---|---|
| CONMED Corporation | May 18, 2026 | Advisory vote to approve named executive officer compensation. | Say-on-Pay | Board | AGAINST | 2 | |
| Camping World Holdings, Inc. | May 21, 2026 | Approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 2 | |
| Century Communities, Inc. | May 6, 2026 | To approve, on an advisory basis, our executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| Coats Group Plc | May 20, 2026 | Authorise Issue of Equity without Pre-emptive Rights | Capital Structure | Board | AGAINST | 2 | |
| Coats Group Plc | May 20, 2026 | Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital Investment | Capital Structure | Board | AGAINST | 2 | |
| DPC Dash Ltd. | May 28, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 2 | |
| Denali Therapeutics Inc. | June 3, 2026 | Advisory vote on executive compensation. | Say-on-Pay | Board | AGAINST | 2 | |
| Deutsche Lufthansa AG | May 12, 2026 | Approve Remuneration Report | Compensation | Board | AGAINST | 2 | |
| Digital Realty Trust, Inc. | May 29, 2026 | Election of Directors: Mary Hogan Preusse | Director Elections | Board | AGAINST | 2 | |
| Dr. Lal PathLabs Limited | December 7, 2025 | Approve Dr. Lal PathLabs Employee Restricted Stock Unit Plan 2025 | Compensation | Board | AGAINST | 2 | |
| Dr. Lal PathLabs Limited | December 7, 2025 | Approve Grant Options to the Employees of the Subsidiary Company(ies) under Dr. Lal PathLabs Employee Restricted Stock Unit Plan 2025 | Compensation | Board | AGAINST | 2 | |
| Dr. Lal PathLabs Limited | December 7, 2025 | Approve Provision of Money to be Provided by the Company for Purchase of Its Own Share by the Trust under Dr. Lal PathLabs Employee Restricted Stock Unit Plan 2025 | Compensation | Board | AGAINST | 2 | |
| Dr. Lal PathLabs Limited | December 7, 2025 | Approve Secondary Acquisition of Shares through Trust Route for the Implementation of Dr. Lal PathLabs Employee Restricted Stock Unit Plan 2025 | Compensation | Board | AGAINST | 2 | |
| Duolingo, Inc. | June 3, 2026 | To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 2 | |
| Elastic N.V. | September 30, 2025 | Non-binding advisory vote to approve the compensation of the Company's named executive officers as described in the proxy statement | Say-on-Pay | Board | AGAINST | 2 | |
| Emaar Development PJSC | March 26, 2026 | Elect Ahmed Jawah as Director | Director Elections | Board | ABSTAIN | 2 | |
| Emaar Development PJSC | March 26, 2026 | Elect Ali Al Mutawaa as Director | Director Elections | Board | ABSTAIN | 2 | |
| Emaar Development PJSC | March 26, 2026 | Elect Zaynab Al Baloushi as Director | Director Elections | Board | ABSTAIN | 2 | |
| FIT Hon Teng Limited | May 26, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 2 | |
| FIT Hon Teng Limited | May 26, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 2 | |
| Fast Retailing Co., Ltd. | November 27, 2025 | Elect Director Shintaku, Masaaki | Director Elections | Board | AGAINST | 2 | |
| FinecoBank SpA | April 29, 2026 | Elect Alberto Marone as Director | Director Elections | Board | AGAINST | 2 | |
| FinecoBank SpA | April 29, 2026 | Elect Francesco Signoretti as Director | Director Elections | Board | AGAINST | 2 | |
| FinecoBank SpA | April 29, 2026 | Elect Gabriella Scapicchio as Director | Director Elections | Board | AGAINST | 2 | |
| FinecoBank SpA | April 29, 2026 | Elect Giuseppe Pisani as Director | Director Elections | Board | AGAINST | 2 | |
| FinecoBank SpA | April 29, 2026 | Elect Maria Giovanna Calloni as Director | Director Elections | Board | AGAINST | 2 | |
| FinecoBank SpA | April 29, 2026 | Elect Micaela Cristina Capelli as Director | Director Elections | Board | AGAINST | 2 | |
| FinecoBank SpA | April 29, 2026 | Elect Stefano Blotto as Director | Director Elections | Board | AGAINST | 2 | |
| FirstCash Holdings, Inc. | June 9, 2026 | Approve the reincorporation of the Company to the State of Texas by conversion. | Extraordinary Transactions | Board | AGAINST | 2 | |
| GEK Terna SA | June 16, 2026 | Authorize Share Capital Increase and/or Issuance of Convertible Bonds without Preemptive Rights | Capital Structure | Board | AGAINST | 2 | |
| GitLab Inc. | June 17, 2026 | Approve, on a non-binding advisory basis, the compensation paid by GitLab Inc. to its named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| Goodman Group | November 11, 2025 | Approve the Spill Resolution | Compensation | Board | AGAINST | 2 | |
| Goosehead Insurance, Inc. | May 4, 2026 | Non-binding and advisory resolution approving the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| Haitian International Holdings Limited | May 22, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 2 | |
| Haitian International Holdings Limited | May 22, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 2 | |
| Halyk Bank of Kazakhstan JSC | April 23, 2026 | Elect Zhomart Nurabayev as Director | Director Elections | Board | AGAINST | 2 | |
| Harbin Electric Company Limited | May 22, 2026 | Approve General Mandate to Issue H Shares | Capital Structure | Board | AGAINST | 2 | |
| Henderson Land Development Company Limited | June 2, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 2 | |
| Henderson Land Development Company Limited | June 2, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 2 | |
| Hill & Smith Plc | May 21, 2026 | Authorise Issue of Equity without Pre-emptive Rights | Capital Structure | Board | AGAINST | 2 | |
| Hill & Smith Plc | May 21, 2026 | Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital Investment | Capital Structure | Board | AGAINST | 2 | |
| Hiscox Ltd. | May 14, 2026 | Authorise Issue of Equity without Pre-emptive Rights | Capital Structure | Board | AGAINST | 2 | |
| Hiscox Ltd. | May 14, 2026 | Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital Investment | Capital Structure | Board | AGAINST | 2 | |
| Humana Inc. | April 16, 2026 | Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2026 proxy statement. | Say-on-Pay | Board | AGAINST | 2 | |
| IDEAYA Biosciences, Inc. | June 16, 2026 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders; and | Say-on-Pay | Board | AGAINST | 2 | |
| Impro Precision Industries Limited | May 26, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 2 | |
| Impro Precision Industries Limited | May 26, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 2 | |
| Inox Wind Limited | June 22, 2026 | Approve Continuation of Directorship of Mukesh Manglik as Non-Executive Director | Director Elections | Board | AGAINST | 2 | |
| Intapp, Inc. | November 18, 2025 | To conduct an advisory vote to approve named executive officer compensation ("Say-On-Pay Vote"). | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| International Workplace Group Plc | May 19, 2026 | Authorise Issue of Equity without Pre-emptive Rights | Capital Structure | Board | AGAINST | 2 | |
| International Workplace Group Plc | May 19, 2026 | Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital Investment | Capital Structure | Board | AGAINST | 2 | |
| Israel Discount Bank Ltd. | September 15, 2025 | Elect Esti Peshin as Director | Director Elections | Board | ABSTAIN | 2 | |
| Israel Discount Bank Ltd. | September 15, 2025 | Elect Gur Nabel as External Director | Director Elections | Board | ABSTAIN | 2 | |
| Israel Discount Bank Ltd. | June 17, 2026 | Elect Amalia Avramov as Director | Director Elections | Board | AGAINST | 2 | |
| Israel Discount Bank Ltd. | June 17, 2026 | Elect Ohad Marani as External Director | Director Elections | Board | AGAINST | 2 | |
| Israel Discount Bank Ltd. | June 17, 2026 | Elect Yaniv Garty as Director | Director Elections | Board | AGAINST | 2 | |
| JD Health International Inc. | June 29, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 2 | |
| JD Health International Inc. | June 29, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 2 | |
| Janus Henderson Group Plc | May 29, 2026 | Advisory Say-on-Pay Vote on Executive Compensation. | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| KGHM Polska Miedz SA | June 9, 2026 | Elect Supervisory Board Member | Director Elections | Board | ABSTAIN | 2 | |
| Kadokawa Corp. | June 24, 2026 | Elect Director Natsuno, Takeshi | Director Elections | Board | AGAINST | 2 | |
| KalVista Pharmaceuticals, Inc. | October 1, 2025 | Approval, on a non-binding advisory basis, of the compensation paid by us to our named executive officers as disclosed in the Proxy Statement. | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| Kymera Therapeutics, Inc. | June 24, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers; and | Say-on-Pay | Board | AGAINST | 2 | |
| Lamb Weston Holdings, Inc. | September 25, 2025 | Election of Directors: Andre J. Hawaux | Director Elections | Board | AGAINST | 2 | |
| Lamb Weston Holdings, Inc. | September 25, 2025 | Election of Directors: Hala G. Moddelmog | Director Elections | Board | AGAINST | 2 | |
| Lamb Weston Holdings, Inc. | September 25, 2025 | Election of Directors: Peter J. Bensen | Director Elections | Board | AGAINST | 2 | |
| Lamb Weston Holdings, Inc. | September 25, 2025 | Election of Directors: Robert J. Coviello | Director Elections | Board | AGAINST | 2 | |
| Lennar Corporation | April 8, 2026 | Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Amy Banse | Director Elections | Board | AGAINST | 2 | |
| Lennar Corporation | April 8, 2026 | Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Sherrill W. Hudson | Director Elections | Board | AGAINST | 2 | |
| Lennar Corporation | April 8, 2026 | Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Stuart Miller | Director Elections | Board | AGAINST | 2 | |
| Lennar Corporation | April 8, 2026 | Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Teri P. McClure | Director Elections | Board | AGAINST | 2 | |
| MARA Holdings, Inc. | June 18, 2026 | Approval of an amendment to our Amended and Restated 2018 Equity Incentive Plan (the "2018 Plan") to increase the number of shares of our common stock reserved under the 2018 Plan by 18 million shares. | Compensation | Board | AGAINST | 2 | |
| MARUWA CO., LTD. | June 19, 2026 | Approve Allocation of Income, with a Final Dividend of JPY 51 | Capital Structure | Board | AGAINST | 2 | |
| MARUWA CO., LTD. | June 19, 2026 | Elect Director Kambe, Toshiro | Director Elections | Board | AGAINST | 2 | |
| Magnite, Inc. | June 8, 2026 | Approval, on an advisory basis, of the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 2 | |
| Marqeta, Inc. | June 10, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| Mayr-Melnhof Karton AG | April 29, 2026 | Approve Remuneration Policy | Compensation | Board | AGAINST | 2 | |
| Mayr-Melnhof Karton AG | April 29, 2026 | Approve Remuneration Report | Compensation | Board | AGAINST | 2 | |
| Minth Group Limited | June 30, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 2 | |
| Mirum Pharmaceuticals, Inc. | June 15, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| Moelis & Company | June 25, 2026 | To approve, on an advisory basis, the compensation of our Named Executive Officers. | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| NMI Holdings, Inc. | May 14, 2026 | Advisory approval of NMI Holdings, Inc.'s executive compensation. | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| Nanobiotix SA | June 9, 2026 | Approve Issuance of Equity or Equity-Linked Securities Reserved for Industrial Companies, Institutions or Entities Active in the Health or Biotechnology Sector, up to Aggregate Nominal Amount of EUR 1,452,302.54 | Capital Structure | Board | AGAINST | 2 | |
| Nanobiotix SA | June 9, 2026 | Approve Issuance of Equity or Equity-Linked Securities Reserved for Qualified Investors Active in the Health or Biotechnology Sector and Financial Institutions, up to Aggregate Nominal Amount of EUR 1,452,302.54 | Capital Structure | Board | AGAINST | 2 | |
| Nanobiotix SA | June 9, 2026 | Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries in the Framework of an Equity Line, up to Aggregate Nominal Amount of EUR 1,452,302.54 | Capital Structure | Board | AGAINST | 2 | |
| Nanobiotix SA | June 9, 2026 | Approve Issuance of Equity or Equity-Linked Securities for One or More Specifically Designated Persons up to 30 Percent of Issued Share Capital | Capital Structure | Board | AGAINST | 2 | |
| Nanobiotix SA | June 9, 2026 | Approve Issuance of Equity or Equity-Linked Securities for Private Placements up to Aggregate Nominal Amount of EUR 1,452,302.54 | Capital Structure | Board | AGAINST | 2 | |
| Nanobiotix SA | June 9, 2026 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Under Items 19-21, 23 and 25-26 | Capital Structure | Board | AGAINST | 2 | |
| Nanobiotix SA | June 9, 2026 | Authorize Capital Increase of Up to EUR 1,452,302.54 for Future Exchange Offers | Capital Structure | Board | AGAINST | 2 | |
| Nanobiotix SA | June 9, 2026 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans | Compensation | Board | AGAINST | 2 | |
| Nanobiotix SA | June 9, 2026 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 1,452,302.54 | Capital Structure | Board | AGAINST | 2 | |
| Nippon Television Holdings, Inc. | June 26, 2026 | Elect Director Sugiyama, Yoshikuni | Director Elections | Board | AGAINST | 2 | |
| Nitori Holdings Co., Ltd. | June 25, 2026 | Elect Director Nitori, Akio | Director Elections | Board | AGAINST | 2 | |
| Nitori Holdings Co., Ltd. | June 25, 2026 | Elect Director Shirai, Toshiyuki | Director Elections | Board | AGAINST | 2 | |
| Nurix Therapeutics, Inc. | May 15, 2026 | To approve, a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. | Say-on-Pay | Board (inferred) | AGAINST | 2 | |
| OdontoPrev SA | April 6, 2026 | Approve Independent Firm's Appraisals | Extraordinary Transactions | Board | AGAINST | 2 | |
| OdontoPrev SA | April 6, 2026 | Approve Merger Agreement between the Company and Bradesco Gestao de Saude S.A. (BGS) | Extraordinary Transactions | Board | AGAINST | 2 | |
| OdontoPrev SA | April 6, 2026 | Approve the Transfer of the Company's Dental Plan Portfolio and Other Operational Assets and Liabilities to Mediservice Operadora de Planos de Saude S.A., Which, as of This Date, Is an Indirect Subsidiary of BGS | Extraordinary Transactions | Board | AGAINST | 2 | |
| OdontoPrev SA | April 6, 2026 | Ratify Apsis Consultoria e Avaliacoes Ltda. as Independent Firm to Appraise Proposed Transaction | Extraordinary Transactions | Board | AGAINST | 2 | |
| PFISTERER Holding SE | June 11, 2026 | Approve Creation of EUR 9 Million Pool of Authorized Capital with or without Exclusion of Preemptive Rights | Capital Structure | Board | AGAINST | 2 |
← Previous Page 5 of 9 Next →
← Back to Capital Group 2025-2026 overview
Built November 19, 2026 from SEC Form N-PX filings.